0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug/Vaccine Safety
 1-20 of 166 Articles
Research Letter |  ONLINE FIRST
Alene Kennedy-Hendricks, PhD; Andrea Gielen, ScD; Eileen McDonald, MS; et al.
JAMA Intern Med. Published online June 13, 2016. doi:10.1001/jamainternmed.2016.2543

Viewpoint |  ONLINE FIRST
Alex John London, PhD; Jonathan Kimmelman, PhD
JAMA Intern Med. Published online June 13, 2016. doi:10.1001/jamainternmed.2016.2534

Original Investigation | 
Angel Y. S. Wong, BSc; Ian C. K. Wong, PhD; Celine S. L. Chui, MSc; et al.
JAMA Intern Med. 2016;176(6):828-834. doi:10.1001/jamainternmed.2016.1586.
Includes: CME, Supplemental Content

Editorial | 
Joshua M. Sharfstein, MD; Jeremy Greene, MD, PhD
JAMA Intern Med. 2016;176(6):733-734. doi:10.1001/jamainternmed.2016.1720.

Research Letter | 
Aaron S. Kesselheim, MD, JD, MPH; Joshua J. Gagne, PharmD, ScD; Wesley Eddings, PhD; et al.
JAMA Intern Med. 2016;176(6):845-847. doi:10.1001/jamainternmed.2016.1688.

Editorial | 
Mitchell H. Katz, MD
JAMA Intern Med. 2016;176(5):599-601. doi:10.1001/jamainternmed.2016.0664.

Viewpoint | 
Brian T. Bateman, MD, MSc; Niteesh K. Choudhry, MD, PhD
JAMA Intern Med. 2016;176(5):583-584. doi:10.1001/jamainternmed.2016.0544.

Editorial | 
Steven Woloshin, MD, MS; Lisa M. Schwartz, MD, MS
JAMA Intern Med. 2016;176(4):439-442. doi:10.1001/jamainternmed.2016.0073.

Original Investigation | 
Loes Jaspers, MD; Frederik Feys, MSc, PhD; Wichor M. Bramer, BSc; et al.
JAMA Intern Med. 2016;176(4):453-462. doi:10.1001/jamainternmed.2015.8565.
Includes: CME, Supplemental Content

Invited Commentary | 
Jeffrey L. Schnipper, MD, MPH
JAMA Intern Med. 2016;176(4):471-472. doi:10.1001/jamainternmed.2015.8562.

Original Investigation | 
Ajit A. Dhavle, PharmD, MBA; Yuze Yang, PharmD; Michael T. Rupp, PhD; et al.
JAMA Intern Med. 2016;176(4):463-470. doi:10.1001/jamainternmed.2015.7786.

Invited Commentary | 
Michael A. Steinman, MD
JAMA Intern Med. 2016;176(4):482-483. doi:10.1001/jamainternmed.2015.8597.

Original Investigation | 
Dima M. Qato, PharmD, MPH, PhD; Jocelyn Wilder, MPH; L. Philip Schumm, MA; et al.
JAMA Intern Med. 2016;176(4):473-482. doi:10.1001/jamainternmed.2015.8581.
Includes: Supplemental Content

Research Letter | 
Christopher M. Jones, PharmD, MPH; Peter G. Lurie, MD, MPH; Douglas C. Throckmorton, MD
JAMA Intern Med. 2016;176(3):399-402. doi:10.1001/jamainternmed.2015.7799.

Viewpoint | 
Amy Kapczynski, JD
JAMA Intern Med. 2016;176(3):295-296. doi:10.1001/jamainternmed.2015.8155.

Editorial | 
Steven R. Cummings, MD; Douglas P. Kiel, MD, MPH; Dennis M. Black, PhD
JAMA Intern Med. 2016;176(2):171-172. doi:10.1001/jamainternmed.2015.7568.

Original Investigation | 
Heike A. Bischoff-Ferrari, MD, DrPH; Bess Dawson-Hughes, MD; E. John Orav, PhD; et al.
JAMA Intern Med. 2016;176(2):. doi:10.1001/jamainternmed.2015.7148.
Includes: Supplemental Content

Perspective | 
Fiona Clement, PhD
JAMA Intern Med. 2016;176(2):163-164. doi:10.1001/jamainternmed.2015.7186.

Original Investigation | 
Benjamin Lazarus, MBBS; Yuan Chen, MS; Francis P. Wilson, MD, MS; et al.
JAMA Intern Med. 2016;176(2):. doi:10.1001/jamainternmed.2015.7193.

Original Investigation | 
Ajay Dharod, MD; Elsayed Z. Soliman, MD, MSc, MS; Farah Dawood, MD; et al.
JAMA Intern Med. 2016;176(2):219-227. doi:10.1001/jamainternmed.2015.7655.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Invited Commentary  | 
Cardiac Protection in HER2-Targeted Treatment How Should We Measure New Strategies?
Ana Barac, MD, PhD; Sandra M. Swain, MD
JAMA Oncology
Original Investigation  | 
Angiotensin II–Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer A Randomized Clinical Trial
Annelies H. Boekhout, PhD; Jourik A. Gietema, MD, PhD; Bojana Milojkovic Kerklaan, PhD; et al.
JAMA
News From the Food and Drug Administration  | 
Olanzapine Linked With Potentially Fatal Skin Reaction
Rebecca Voelker, MSJ
JAMA Psychiatry
Original Investigation  | 
Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression A Randomized Clinical Trial
Jorge A. Quiroz, MD, MBA; Paul Tamburri, PharmD; Dennis Deptula, PhD; et al.